Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling

Neuron

Volumn 78, Issue 3, 2013, Pages 498-509

  Földy, Csaba ^a   Malenka, Robert C ^a   Südhof, Thomas C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; CHOLECYSTOKININ; ENDOCANNABINOID; NEUROLIGIN; NEUROLIGIN 3; PARVALBUMIN; UNCLASSIFIED DRUG;

4 AMINOBUTYRIC ACID RELEASE; AMINO ACID SUBSTITUTION; ANIMAL TISSUE; ARTICLE; AUTISM; BASKET CELL; CONTROLLED STUDY; GABAERGIC TRANSMISSION; GENE MUTATION; HIPPOCAMPAL CA1 REGION; LONG TERM DEPRESSION; MOUSE; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SIGNAL TRANSDUCTION; SYNAPSE; SYNAPTIC TRANSMISSION;

ANIMALS; CELL ADHESION MOLECULES, NEURONAL; CELLS, CULTURED; CHOLECYSTOKININ; ENDOCANNABINOIDS; GABAERGIC NEURONS; GENE KNOCK-IN TECHNIQUES; HIPPOCAMPUS; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MUTATION; NERVE TISSUE PROTEINS; NEURONS; PARVALBUMINS; SIGNAL TRANSDUCTION; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84877336575     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2013.02.036     Document Type: Article

References (52)

1. Alger B.E. Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog. Neurobiol. 2002, 68:247-286.
2. Alger B.E. Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know. J. Physiol. 2012, 590:2203-2212.
3. Alger B.E., Kim J. Supply and demand for endocannabinoids. Trends Neurosci. 2011, 34:304-315.
4. Ali A.B., Todorova M. Asynchronous release of GABA via tonic cannabinoid receptor activation at identified interneuron synapses in rat CA1. Eur. J. Neurosci. 2010, 31:1196-1207.
5. Bartos M., Vida I., Jonas P. Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat. Rev. Neurosci. 2007, 8:45-56.
6. Baudouin S.J., Gaudias J., Gerharz S., Hatstatt L., Zhou K., Punnakkal P., Tanaka K.F., Spooren W., Hen R., De Zeeuw C.I., et al. Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism. Science 2012, 338:128-132.
7. Biró A.á., Holderith N.B., Nusser Z. Release probability-dependent scaling of the postsynaptic responses at single hippocampal GABAergic synapses. J. Neurosci. 2006, 26:12487-12496.
8. Budreck E.C., Scheiffele P. Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic synapses. Eur. J. Neurosci. 2007, 26:1738-1748.
9. Castillo P.E., Chiu C.Q., Carroll R.C. Long-term plasticity at inhibitory synapses. Curr. Opin. Neurobiol. 2011, 21:328-338.
10. Chadman K.K., Gong S., Scattoni M.L., Boltuck S.E., Gandhy S.U., Heintz N., Crawley J.N. Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Res. 2008, 1:147-158.
11. Chevaleyre V., Castillo P.E. Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 2003, 38:461-472.
12. Chubykin A.A., Atasoy D., Etherton M.R., Brose N., Kavalali E.T., Gibson J.R., Südhof T.C. Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2. Neuron 2007, 54:919-931.
13. Cravatt B.F., Lichtman A.H. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Curr. Opin. Chem. Biol. 2003, 7:469-475.
14. De Jaco A., Dubi N., Comoletti D., Taylor P. Folding anomalies of neuroligin3 caused by a mutation in the alpha/beta-hydrolase fold domain. Chem. Biol. Interact. 2010, 187:56-58.
15. Etherton M.R., Földy C., Sharma M., Tabuchi K., Liu X., Shamloo M., Malenka R.C., Südhof T.C. Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function. Proc. Natl. Acad. Sci. USA 2011, 108:13764-13769.
16. Etherton M.R., Tabuchi K., Sharma M., Ko J., Südhof T.C. An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus. EMBO J. 2011, 30:2908-2919.
17. Földy C., Neu A., Jones M.V., Soltesz I. Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release. J. Neurosci. 2006, 26:1465-1469.
18. Földy C., Lee S.H., Morgan R.J., Soltesz I. Regulation of fast-spiking basket cell synapses by the chloride channel ClC-2. Nat. Neurosci. 2010, 13:1047-1049.
19. Freund T.F. Interneuron diversity series: Rhythm and mood in perisomatic inhibition. Trends Neurosci. 2003, 26:489-495.
20. Freund T.F., Katona I. Perisomatic inhibition. Neuron 2007, 56:33-42.
21. Freund T.F., Katona I., Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 2003, 83:1017-1066.
22. Gibson J.R., Huber K.M., Südhof T.C. Neuroligin-2 deletion selectively decreases inhibitory synaptic transmission originating from fast-spiking but not from somatostatin-positive interneurons. J. Neurosci. 2009, 29:13883-13897.
23. Glickfeld L.L., Atallah B.V., Scanziani M. Complementary modulation of somatic inhibition by opioids and cannabinoids. J. Neurosci. 2008, 28:1824-1832.
24. Graf E.R., Zhang X., Jin S.X., Linhoff M.W., Craig A.M. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 2004, 119:1013-1026.
25. Hentges S.T., Low M.J., Williams J.T. Differential regulation of synaptic inputs by constitutively released endocannabinoids and exogenous cannabinoids. J. Neurosci. 2005, 25:9746-9751.
26. Hoffman A.F., Laaris N., Kawamura M., Masino S.A., Lupica C.R. Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors. J. Neurosci. 2010, 30:545-555.
27. Hoon M., Soykan T., Falkenburger B., Hammer M., Patrizi A., Schmidt K.F., Sassoè-Pognetto M., Löwel S., Moser T., Taschenberger H., et al. Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. Proc. Natl. Acad. Sci. USA 2011, 108:3053-3058.
28. Ichtchenko K., Hata Y., Nguyen T., Ullrich B., Missler M., Moomaw C., Südhof T.C. Neuroligin 1: a splice site-specific ligand for beta-neurexins. Cell 1995, 81:435-443.
29. Ichtchenko K., Nguyen T., Südhof T.C. Structures, alternative splicing, and neurexin binding of multiple neuroligins. J. Biol. Chem. 1996, 271:2676-2682.
30. Jamain S., Quach H., Betancur C., Råstam M., Colineaux C., Gillberg I.C., Soderstrom H., Giros B., Leboyer M., Gillberg C., Bourgeron T. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 2003, 34:27-29. Paris Autism Research International Sibpair Study.
31. Kaeser P.S., Deng L., Fan M., Südhof T.C. RIM genes differentially contribute to organizing presynaptic release sites. Proc. Natl. Acad. Sci. USA 2012, 109:11830-11835.
32. Katona I., Freund T.F. Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat. Med. 2008, 14:923-930.
33. Katona I., Freund T.F. Multiple functions of endocannabinoid signaling in the brain. Annu. Rev. Neurosci. 2012, 35:529-558.
34. Kim J., Alger B.E. Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Nat. Neurosci. 2010, 13:592-600.
35. Klausberger T., Somogyi P. Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science 2008, 321:53-57.
36. Klausberger T., Marton L.F., O'Neill J., Huck J.H., Dalezios Y., Fuentealba P., Suen W.Y., Papp E., Kaneko T., Watanabe M., et al. Complementary roles of cholecystokinin- and parvalbumin-expressing GABAergic neurons in hippocampal network oscillations. J. Neurosci. 2005, 25:9782-9793.
37. Ko J., Fuccillo M.V., Malenka R.C., Südhof T.C. LRRTM2 functions as a neurexin ligand in promoting excitatory synapse formation. Neuron 2009, 64:791-798.
38. Lisman J.E., Coyle J.T., Green R.W., Javitt D.C., Benes F.M., Heckers S., Grace A.A. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 2008, 31:234-242.
39. Losonczy A., Biró A.A., Nusser Z. Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons. Proc. Natl. Acad. Sci. USA 2004, 101:1362-1367.
40. Neu A., Földy C., Soltesz I. Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus. J. Physiol. 2007, 578:233-247.
41. Piomelli D. The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 2003, 4:873-884.
42. Pitler T.A., Alger B.E. Depolarization-induced suppression of GABAergic inhibition in rat hippocampal pyramidal cells: G protein involvement in a presynaptic mechanism. Neuron 1994, 13:1447-1455.
43. Poulopoulos A., Aramuni G., Meyer G., Soykan T., Hoon M., Papadopoulos T., Zhang M., Paarmann I., Fuchs C., Harvey K., et al. Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin. Neuron 2009, 63:628-642.
44. Sanders S.J., Ercan-Sencicek A.G., Hus V., Luo R., Murtha M.T., Moreno-De-Luca D., Chu S.H., Moreau M.P., Gupta A.R., Thomson S.A., et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011, 70:863-885.
45. Silver R.A. Estimation of nonuniform quantal parameters with multiple-probability fluctuation analysis: theory, application and limitations. J. Neurosci. Methods 2003, 130:127-141.
46. Song J.Y., Ichtchenko K., Südhof T.C., Brose N. Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses. Proc. Natl. Acad. Sci. USA 1999, 96:1100-1105.
47. Südhof T.C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008, 455:903-911.
48. Szabó G.G., Holderith N., Gulyás A.I., Freund T.F., Hájos N. Distinct synaptic properties of perisomatic inhibitory cell types and their different modulation by cholinergic receptor activation in the CA3 region of the mouse hippocampus. Eur. J. Neurosci. 2010, 31:2234-2246.
49. Tabuchi K., Blundell J., Etherton M.R., Hammer R.E., Liu X., Powell C.M., Südhof T.C. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007, 318:71-76.
50. Varoqueaux F., Jamain S., Brose N. Neuroligin 2 is exclusively localized to inhibitory synapses. Eur. J. Cell Biol. 2004, 83:449-456.
51. Varoqueaux F., Aramuni G., Rawson R.L., Mohrmann R., Missler M., Gottmann K., Zhang W., Südhof T.C., Brose N. Neuroligins determine synapse maturation and function. Neuron 2006, 51:741-754.
52. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 2001, 410:588-592.